stockrow
Friday 6 November 2026
Export PLYX’s income statement to Excel — free account
Polaryx Therapeutics, Inc.
PLYX Healthcare Biotechnology
1.80
0.00
0.00%
Follow PLYX
Alert me
Polaryx Therapeutics, Inc. (PLYX) P/E ratio
Polaryx Therapeutics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GNLX Genelux Corporation compare | n/m |
| NRXS Neuraxis, Inc. compare | n/m |
| EQ Equillium, Inc. compare | n/m |
| PLYX Polaryx Therapeutics, Inc. | n/m |
| TNXP Tonix Pharmaceuticals Holding Corp. compare | n/m |
| SEER Seer, Inc. compare | n/m |
| KZIA Novogen Limited compare | n/m |
| VXRT VAXART, INC. compare | 2.8× |
| RLYB Rallybio Corporation compare | 3.3× |
| Biotechnology industry median | 10.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)